Michelle Kim, MD
Urology · Hackensack, NJNPI 1689896722
Payments from drug & device makers
Across 39 payments — averaging $36.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$332
- Calyxo, Inc.$328
- Procept Biorobotics Corporation$186
- Axonics, Inc.$149
- Urogen Pharma, Inc.$77
- Pfizer$59
- plus $298 from 11 others
What the payments were for
- Food & beverage$1,37096%
- Education$594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 7 | $332 |
| Calyxo, Inc. | 4 | $328 |
| Procept Biorobotics Corporation | 1 | $186 |
| Axonics, Inc. | 1 | $149 |
| Urogen Pharma, Inc. | 5 | $77 |
| Pfizer | 4 | $59 |
| Medtronic(2 entities) | 3 | $48 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $42 |
| AbbVie | 2 | $37 |
| Johnson & Johnson | 2 | $30 |
| Ambu Inc. | 1 | $26 |
| Eisai Inc. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| KARL Storz Endoscopy-america | 1 | $21 |
| Kerecis Limited | 1 | $20 |
| Dentsply IH AB | 1 | $17 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUABEAM SYSTEM$186
- Bulkamid$149
- Axonics$149
How this compares
$1,429 in reported general payments places this provider in the 35th percentile of 401 urology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 259 | $230,537 |
| GemtesaVibegron | 100 | $103,219 |
| Estradiol | 191 | $12,627 |
| Solifenacin Succinate | 121 | $8,852 |
| Tolterodine Tartrate ErTolterodine Tartrate | 72 | $7,398 |
| Potassium Citrate ErPotassium Citrate | 35 | $6,140 |
| Tamsulosin Hcl | 333 | $5,853 |
| Oxybutynin Chloride ErOxybutynin Chloride | 77 | $3,037 |
| Methenamine Hippurate | 24 | $2,678 |
| Finasteride | 85 | $1,592 |
| Dutasteride | 32 | $1,275 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 43 | $960 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 80 | $863 |
| Cephalexin | 150 | $842 |
| NitrofurantoinNitrofurantoin Macrocrystal | 12 | $644 |
Paid to pharmacies, not to this prescriber.
Other urology in Hackensack
- Nitin YerramHackensack$1.6M
- Michael StifelmanHackensack$1.5M
- Ravi MunverHackensack$529K
- Bethany DesrochesHackensack$32K
- Grace ChenHackensack$31K
- Gordon BrownCherry Hill$2.8M
- Thomas MuellerLinwood$1.2M
- David SussmanLinwood$833K
- Michael IngberDenville$607K
- Grannum SantBridgewater$487K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.